Metropolitan Life Insurance Company (MetLife)’s Precision BioSciences DTIL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-463	Closed	-$103K	–	2371
2021 Q4	$103K	Buy	463 +24	+5%	+$6.7K	﹤0.01%	2462
2021 Q3	$152K	Buy	+439	New	+$149K	﹤0.01%	2283
2021 Q2	–	Sell	-415	Closed	-$129K	–	2754
2021 Q1	$129K	Buy	415 +39	+10%	+$13.7K	﹤0.01%	2308
2020 Q4	$94K	Sell	376 -62	-14%	-$15.2K	﹤0.01%	2383
2020 Q3	$81K	Hold	438	–	–	﹤0.01%	2342
2020 Q2	$109K	Buy	438 +26	+6%	+$5.69K	﹤0.01%	2201
2020 Q1	$74.6K	Buy	412 +1	+0.2%	+$262	﹤0.01%	2219
2019 Q4	$171K	Buy	+411	New	+$129K	﹤0.01%	2030

Other funds holding DTIL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OMC

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s DTIL Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Precision BioSciences (DTIL) in Q1 2022, closing a stake of 463 shares — an estimated $103K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DTIL in Q4 2019 and held it in 8 quarters. The position peaked at $171K in Q4 2019. 152 funds tracked by Wall St. Rank hold DTIL as of Q1 2022.

Metropolitan Life Insurance Company (MetLife) reported no remaining Precision BioSciences position as of Q1 2022 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 463 Precision BioSciences shares in Q1 2022, an estimated $103K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Precision BioSciences in Q4 2019 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s Precision BioSciences position peaked at $171K in Q4 2019.
152 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.